GL1X · GenesisL1 explorer

Research workbench

The structure of deoxycytidine kinase complexed with lamivudine and ADP.

Analyse The structure of deoxycytidine kinase complexed with lamivudine and ADP. in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2NOA
Type
protein
Length
464 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Deoxycytidine kinase
EC
2.7.1.74
UniProt
P27707
Ligands
ADP, 3TC
Pockets
4 · best druggability 0.69

Structure

x-ray diffraction · 2 distinct chains · 56% helix, 11% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADeoxycytidine kinase (EC 2.7.1.74)protein24255% helix, 11% strandP27707
BDeoxycytidine kinase (EC 2.7.1.74)protein22257% helix, 12% strandP27707

Ligands and binding sites

  • ADP · Adenosine-5'-diphosphate · ligand · 2 copies · chains A, B
  • 3TC · 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11900.690.8740ADP, 3TC
21940.680.8636ADP, 3TC
31940.440.7329empty
4690.390.7920empty

Interfaces

1 interface between chains.

  • A–B · 1339 Ų buried · 14 hydrogen bonds · protein-protein

Compared structures

  • 2NOA · The structure of deoxycytidine kinase complexed with lamivudine and ADP. · the same entry in another collection · chain A against A, TM-score 1.00
  • P27707 · AlphaFold monomer V2.0 prediction for deoxycytidine kinase (P27707) · a predicted model of the same protein · chain B against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.